MENU

Dr. Jeffrey Farma Elected to Leadership Position in the Society of University Surgeons

December 17, 2021

Dr. Jeffrey Farma, chief of General Surgery at Fox ChaseDr. Jeffrey Farma, chief of General Surgery at Fox Chase

PHILADELPHIA (December 17, 2021)—Jeffrey M. Farma, MD, FACS, chief of the Division of General Surgery and co-director of the Melanoma and Skin Cancer Program at Fox Chase Cancer Center, has been elected a member-at-large for the Society of University Surgeons (SUS). According to the SUS, the member-at-large position is an important part of its nominating committee. 

“I am very grateful to be have been elected to this position by my peers,” said Farma, who is also program director of the Complex General Surgical Oncology Fellowship at Fox Chase. “It’s very humbling to be acknowledged by fellow professionals in this way.”

Membership in the SUS is bestowed upon surgeons who are well-established and who have demonstrated scholarly or creative ability that positively impacts their field. Members must be a faculty member in a university department of surgery and its affiliated teaching hospital and have completed a graduate university residency training in surgery. Their work as a surgeon, teacher, and investigator must demonstrate promise of a successful career in academic surgery.

The benefits of being an SUS member include having access to research grant opportunities such as the American Surgical Association Surgical Leaders Fellowship Grant, the opportunity to mentor a resident for the SUS Resident Research Scholar Award, and the opportunity to sponsor those currently within their first three years of a full-time faculty appointment for the Junior Faculty Award.

Farma has been awarded many accolades throughout his career, including Philadelphia Magazine Top Doctors, 2018-2020; the Society of Surgical Oncology European Society of Surgical Oncology Observership in 2019; and the Castle Connelly national list of Top Doctors, Regional Top Doctor 2014-17. He is also a member of multiple prestigious societies, including the American College of Surgeons, the Metropolitan Philadelphia American College of Surgeons, and the Pennsylvania Medical Society.

The mission of the SUS is to support and advance leaders in academic surgery. The SUS Foundation partners with the SUS to further promote academic surgery through the support of surgical science and education. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase